Profile picture

Associate Professor Marco Canepa

University of Genoa - Department of Health Sciences, Genoa (Italy)
Follow
Biography
Professor Marco Canepa took is MD degree in 2006 at the University of Genova, Italy, where he also obtained his fellowship in Cardiology and PhD degree. In late 2010 he moved to Baltimore, MD, USA, where he worked as Research Fellow at the NIA/NIH under the supervision of Dr. Lakatta and Ferrucci, and joined the HCM Clinic of the Johns Hopkins Medical School held by Dr. Abraham. In 2013 he was appointed Assistant Professor in Cardiology at the University of Genova, and in 2020 Associate Professor. He is currently co-head of the HF and head of the Cardiomiopathy Clinic at the San Martino Hospital. His main research interests are heart failure and cardiomyopathies. He has ongoing collaborations with national and international research groups. He is fellow of the HFA, member of the Editorial Board of the IJC, active reviewer for renowned cardiovascular journals, and author of more than 100 publications on peer-review journals, in most of which he is first author.
Logo ESC

Contributor content

The weight of co-morbidities: focus on aortic stenosis
Presentation
The weight of co-morbidities: focus on aortic stenosis
Prognostic impact of ICD interventions in a real-world primary and secondary prevention population
Presentation
Prognostic impact of ICD interventions in a real-world primary and secondary prevention population
Clinical characteristics of heart failure patients admitted to internal medicine vs. cardiology units: the VASCO study
Presentation
Clinical characteristics of heart failure patients admitted to internal medicine vs. cardiology units: the VASCO study
Heart therapy: benefits and risks for the lung
Presentation
Heart therapy: benefits and risks for the lung
Prevalence and prognostic impact of chronic obstructive pulmonary disease in patients with chronic heart failure. Data from the GISSI-Heart Failure trial.
Presentation
Prevalence and prognostic impact of chronic obstructive pulmonary disease in patients with chronic heart failure. Data from the GISSI-Heart Failure trial.

ESC 365 is supported by